Showing results (1801-1810 of 1,910) with videos related to
Sort By:
Pageof 191
Bioorganic & Medicinal Chemistry Letters|April 13, 2010
Design, synthesis and structure-activity relationships of novel biarylamine-based Met kinase inhibitorsDavid K Williams, Xiao-Tao Chen, Christine Tarby, et al.Nature Medicine|July 21, 2022
Factors driving provider adoption of the TREWS machine learning-based early warning system and its effects on sepsis treatment timingKatharine E Henry, Roy Adams, Cassandra Parent, et al.Molecular Cancer Therapeutics|April 7, 2016
Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial EvaluationJoo Ern Ang, Rupinder Pandher, Joo Chew Ang, et al.JAMA Neurology|January 19, 2021
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical TrialReisa Sperling, David Henley, Paul S Aisen, et al.Journal of Hepatology|May 21, 2008
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinomaHung Huynh, Pierce K H Chow, Nallasivam Palanisamy, et al.Wellcome Open Research|January 25, 2020
Conducting sexualities research: an outline of emergent issues and case studies from ten Wellcome-funded projectsDylan Kneale, Robert French, Helen Spandler, et al.Trials|October 25, 2017
Development of a core outcome set for clinical trials in basal cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi surveyDaniel I Schlessinger, Sanjana Iyengar, Arianna F Yanes, et al.Human Molecular Genetics|September 12, 2014
Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosisDenny L Cottle, Gloria M A Ursino, Sally Chi Ieng Ip, et al.Journal of Medicinal Chemistry|February 16, 2010
Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt)Tatiana McHardy, John J Caldwell, Kwai-Ming Cheung, et al.Molecular Cancer Therapeutics|June 23, 2017
Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic MelanomaJoo Ern Ang, Akos Pal, Yasmin J Asad, et al.Pageof 191